Monoclonal antibody to tumor necrosis factor-α modulates hepatocellular Ca2+ homeostasis during hemorrhagic shock in the rat

被引:6
|
作者
Pizanis, A [1 ]
Mutschler, W [1 ]
Rose, S [1 ]
机构
[1] Univ Saarland, Dept Trauma Hand & Reconstruct Surg, D-66421 Homburg, Germany
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 1999年 / 77卷 / 01期
关键词
calcium; liver; tumor necrosis factor; hemorrhage; lipid peroxidation;
D O I
10.1007/s001090050291
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Tumor necrosis factor-alpha (TNF-alpha) is a key mediator of shock-induced cellular and humoral inflammatory cascades. The present study investigated the role of TNF-alpha. in oxidative membrane injury and altered hepatocyte Ca2+ regulation, both of which are critical steps in cellular dysfunction during ischemia/reperfusion events. Hemorrhagic shock was induced by bleeding male Sprague-Dawley rats (200-250 g,n=6/group) to a mean arterial blood pressure of 40 mmHG for 60 min. Rats were resuscitated with 60% of shed blood and twice the shed blood volume as Ringers' lactate. At the end of hemorrhage and 60 min after resuscitation, hepatocytes were isolated by liver collagenase perfusion. Hepatocyte Ca2+ uptake (CPup2+) and Ca2+ membrane flux (Ca-flux(2+)) were determined by Ca-45(2+) incubation techniques. Hepatocyte reduced/oxidized glutathione and lipid peroxidation were determined fluorometrically. Both hemorrhage and hemorrhage/resuscitation significantly increased hepatocyte Ca-up(2+) and Ca-flux(2+). The monoclonal chimeric mouse gamma(1) TNF-alpha antibody (TN3 gamma 1.19.12; 20 mg/k, b.w.) given with resuscitation significantly decreased hepatocyte Ca-up(2+) and Ca-flux(2+) and prevented hepatocyte lipid peroxidation. These Findings suggest that oxidative membrane injury could be the result of TNF-alpha modulation of hepatocellular Ca2+ regulation during hemorrhage/resuscitation.
引用
收藏
页码:8 / 13
页数:6
相关论文
共 50 条
  • [21] Tumor necrosis factor-α monoclonal antibody, infliximab, used to manage severe sciatica -: Point of view
    Rydevik, B
    SPINE, 2003, 28 (08) : 753 - 754
  • [22] In vitro and in vivo evaluation of human tumor necrosis factor-α (hTNFα) chemically conjugated to monoclonal antibody
    Pietersz, GA
    Toohey, B
    McKenzie, IFC
    JOURNAL OF DRUG TARGETING, 1998, 5 (02) : 109 - 120
  • [23] Role of Tumor Necrosis Factor-α and Interleukin-1β on lung dysfunction following hemorrhagic shock in rats
    Sato, Hiroaki
    Kasai, Kentaro
    Tanaka, Toshiko
    Kita, Toshiro
    Tanaka, Noriyuki
    MEDICAL SCIENCE MONITOR, 2008, 14 (05): : BR79 - BR87
  • [24] In vivo blockade of tumor necrosis factor-α in patients with rheumatoid arthritis:: Longterm effects after repeated infusion of chimeric monoclonal antibody cA2
    Lorenz, HM
    Grünke, M
    Hieronymus, T
    Antoni, C
    Nüsslein, H
    Schaible, TF
    Manger, B
    Kalden, JR
    JOURNAL OF RHEUMATOLOGY, 2000, 27 (02) : 304 - 310
  • [25] Differential local and systemic tumor necrosis factor-α responses to a second hit of lipopolysaccharide after hemorrhagic shock
    Schulman, AM
    Claridge, JA
    Ghezel-Ayagh, A
    Johnson, O
    Young, JS
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2003, 55 (02): : 298 - 307
  • [26] Role of TNF-alpha in altered hepatocellular Ca2+-regulation during hemorrhagic shock in the rat
    Pizanis, A
    Rose, S
    Dike, J
    Marzi, I
    Mutschler, W
    IMMUNE CONSEQUENCES OF TRAUMA, SHOCK AND SEPSIS - MECHANISMS AND THERAPEUTIC APPROACHES, VOL I: MOF, MODS AND SIRS - BASIC MECHANISMS IN INFLAMMATION AND TISSUE INJURY, 1996, : 948 - 952
  • [27] Induction of tumor necrosis factor receptor type 2 gene expression by tumor necrosis factor-α in rat primary astrocytes
    Lung, HL
    Leung, KN
    Stadlin, A
    Ma, CM
    Tsang, D
    LIFE SCIENCES, 2001, 68 (18) : 2081 - 2091
  • [28] Design and expression of humanized monoclonal antibody f10 that neutralizes human tumor necrosis factor-α.
    Aliev, TK
    Panina, AA
    Radko, BV
    Petrovskaya, LE
    Shingarova, LN
    Nedospasov, SA
    Zav'yalova, GA
    Korobko, VG
    Zav'yalov, VP
    CLINICAL IMMUNOLOGY, 2002, 103 (03) : S90 - S91
  • [29] HEMORRHAGIC TUMOR NECROSIS DURING A PILOT TRIAL OF TUMOR-NECROSIS-FACTOR-ALPHA AND ANTI-GD3 GANGLIOSIDE MONOCLONAL-ANTIBODY IN PATIENTS WITH METASTATIC MELANOMA
    MINASIAN, LM
    SZATROWSKI, TP
    ROSENBLUM, M
    STEFFENS, T
    MORRISON, ME
    CHAPMAN, PB
    WILLIAMS, L
    NATHAN, CF
    HOUGHTON, AN
    BLOOD, 1994, 83 (01) : 56 - 64
  • [30] Effect of cA2 anti-tumor necrosis factor-α antibody therapy on hematopoiesis of patients with myelodysplastic syndromes
    Boula, Anna
    Voulgarelis, Michael
    Giannouli, Stavroula
    Katrinakis, George
    Psyllaki, Maria
    Pontikoglou, Charalambos
    Markidou, Fotini
    Eliopoulos, George D.
    Papadaki, Helen A.
    CLINICAL CANCER RESEARCH, 2006, 12 (10) : 3099 - 3108